• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing the spread of the novel coronavirus in the absence of mass testing.在缺乏大规模检测的情况下评估新型冠状病毒的传播。
Int J Clin Pract. 2021 Apr;75(4):e13836. doi: 10.1111/ijcp.13836. Epub 2020 Dec 21.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
4
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
5
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
6
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
7
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.急诊科入院时假设的 SARS-CoV-2 即时检测模型:快速成本效益分析。
Health Technol Assess. 2021 Mar;25(21):1-68. doi: 10.3310/hta25210.
8
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
9
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
10
First Wave of COVID-19 Pandemic in Italy: Data and Evidence.意大利的 COVID-19 大流行第一波:数据和证据。
Adv Exp Med Biol. 2021;1353:91-113. doi: 10.1007/978-3-030-85113-2_6.

引用本文的文献

1
COVID-19: Tail risk and predictive regressions.新冠病毒(COVID-19):尾部风险与预测回归。
PLoS One. 2022 Dec 1;17(12):e0275516. doi: 10.1371/journal.pone.0275516. eCollection 2022.
2
Modeling the Covid-19 epidemic using time series econometrics.使用时间序列计量经济学模型对新冠疫情进行建模。
Health Econ. 2021 Nov;30(11):2808-2828. doi: 10.1002/hec.4413. Epub 2021 Aug 24.
3
Mortality containment vs. Economics Opening: Optimal policies in a SEIARD model.死亡率控制与经济开放:SEIARD模型中的最优政策
J Math Econ. 2021 Mar;93:102490. doi: 10.1016/j.jmateco.2021.102490. Epub 2021 Feb 14.
4
A phenomenological approach to assessing the effectiveness of COVID-19 related nonpharmaceutical interventions in Germany.一种评估德国与新冠疫情相关非药物干预措施有效性的现象学方法。
Saf Sci. 2020 Nov;131:104924. doi: 10.1016/j.ssci.2020.104924. Epub 2020 Jul 21.
5
"Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom.“居家隔离,保护国家医疗服务体系,拯救生命”:英国封城措施的成本效益分析。
Int J Clin Pract. 2021 Mar;75(3):e13674. doi: 10.1111/ijcp.13674. Epub 2020 Sep 21.

本文引用的文献

1
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.血清学检测在 COVID-19 诊断中的准确性:系统评价和荟萃分析。
BMJ. 2020 Jul 1;370:m2516. doi: 10.1136/bmj.m2516.
2
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.估算非药物干预措施对欧洲 COVID-19 疫情的影响。
Nature. 2020 Aug;584(7820):257-261. doi: 10.1038/s41586-020-2405-7. Epub 2020 Jun 8.
3
The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak.无症状传播的时间尺度影响着对 COVID-19 疫情中流行潜力的估计。
Epidemics. 2020 Jun;31:100392. doi: 10.1016/j.epidem.2020.100392. Epub 2020 May 11.
4
A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis.分阶段解锁策略在 COVID-19 大流行期间的应用——基于趋势分析的经验教训。
Int J Clin Pract. 2020 Aug;74(8):e13528. doi: 10.1111/ijcp.13528. Epub 2020 May 19.
5
Estimating the COVID-19 infection rate: Anatomy of an inference problem.估算新冠病毒感染率:一个推理问题剖析
J Econom. 2021 Jan;220(1):181-192. doi: 10.1016/j.jeconom.2020.04.041. Epub 2020 May 6.
6
Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand".评 Ferguson 等人的“减少 COVID-19 死亡率和医疗需求的非药物干预(NPIs)的影响”一文。
Bull Math Biol. 2020 Apr 8;82(4):52. doi: 10.1007/s11538-020-00726-x.
7
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).大量未记录的感染使新型冠状病毒(SARS-CoV-2)迅速传播。
Science. 2020 May 1;368(6490):489-493. doi: 10.1126/science.abb3221. Epub 2020 Mar 16.
8
Covid-19 - Navigating the Uncharted.新冠疫情——探索未知领域。
N Engl J Med. 2020 Mar 26;382(13):1268-1269. doi: 10.1056/NEJMe2002387. Epub 2020 Feb 28.

在缺乏大规模检测的情况下评估新型冠状病毒的传播。

Assessing the spread of the novel coronavirus in the absence of mass testing.

机构信息

Imperial College London, Business School, London, UK.

Atmospheric, Oceanic and Planetary Physics, Oxford University, Oxford, UK.

出版信息

Int J Clin Pract. 2021 Apr;75(4):e13836. doi: 10.1111/ijcp.13836. Epub 2020 Dec 21.

DOI:10.1111/ijcp.13836
PMID:33258191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7744827/
Abstract

BACKGROUND

Assessing why the spread of the COVID-19 virus slowed down in many countries in March through to May of 2020 is of great significance. The relative role of restrictions on behaviour ("lockdowns") and of a natural slowing for other reasons is difficult to assess when mass testing was not widely done. This paper assesses the evolution of the spread of the COVID-19 virus over this period when there was no data on test results for a large, random sample of the population.

METHOD

We estimate a version of the susceptible-infected-recovered model applied to data on the numbers who were tested positive in several countries over the period when the virus spread very fast and then its spread slowed sharply. Up to the end of April 2020, test data came from non-random samples of populations who were overwhelmingly those who displayed symptoms. Using data from a period when the criteria used for testing (which was that people had clear symptoms) was relatively consistent is important in drawing out the message from test results. We use this data to assess two things: how large might be the group of those infected who were not recorded and how effective were lockdown measures in slowing the spread of the infection.

RESULTS

We find that to match data on daily new cases of the virus, the estimated model favours high values for the number of people infected but not recorded.

CONCLUSIONS

Our findings suggest that the infection may have spread far enough in many countries by April 2020 to have been a significant factor behind the fall in measured new cases. Government restrictions on behaviour-lockdowns-were only one factor behind slowing in the spread of the virus.

摘要

背景

评估 2020 年 3 月至 5 月期间 COVID-19 病毒在许多国家传播速度放缓的原因具有重要意义。在未广泛进行大规模检测的情况下,很难评估行为限制(“封锁”)和其他原因导致的自然减缓的相对作用。本文评估了在没有大规模随机人群检测结果数据的情况下,这一时期 COVID-19 病毒传播的演变情况。

方法

我们对几个国家在病毒快速传播然后急剧放缓期间检测呈阳性的人数数据进行了易感-感染-恢复模型的版本估计。截至 2020 年 4 月底,检测数据来自于那些表现出症状的人群的非随机样本。使用在测试中使用的标准(即人们有明显症状)相对一致的时间段的数据对于从检测结果中得出结论非常重要。我们使用这些数据来评估两件事:未记录的感染者群体可能有多大,以及封锁措施在减缓感染传播方面的有效性。

结果

我们发现,要匹配病毒每日新增病例的数据,估计模型倾向于感染但未记录的人数的高值。

结论

我们的研究结果表明,到 2020 年 4 月,感染可能已经在许多国家传播得足够广泛,成为测量新病例下降的一个重要因素。政府对行为的限制——封锁——只是病毒传播放缓的一个因素。